Ann: Cellmid Updates on Distribution of Evolis, page-15

Having bought in several years ago like many here I cant help but err on the side of caution so many false starts only for it to fall back to the normal 2-3c (preconsol) range groundhog day style. However with recent communication of their expansion looking very positive some half decent quarterly numbers surely cannot be too far away. I think the market just wants to see us stand on our own feet and when that happens it will be very hard to keep the price down. Then perhaps we may get are well overdue rewards for our patience with this stock. Having invested for the midkine side of things it has been interesting seeing the Evolis side evolve. If the Evolis success allows the midkine portfolio to thrive then it will be a stroke of genius.